Ryan Elliott

Ryan Elliott

@ryanelliott.bsky.social

Hematology Resident Physician | Former High School Teacher | Piano Enthusiast | Proud Newfoundlander | Millennial https://buymeacoffee.com/ryanelliott

262 Followers 117 Following 122 Posts Joined Nov 2024
2 months ago
Post image

🫁 Just passing on what I thought was a very nice diagram from Med G for respiratory physical examination. Always nice to have some materials on-hand for learners. #medsky #IMsky

1 0 0 0
3 months ago
Post image

Jorge Castillo, MD, shares data on an all-oral, non-chemo, fixed-duration regimen for Waldenström macroglobulinemia using pirtobrutinib and venetoclax. The combination delivered rapid, profound and 100% overall responses with manageable side effects and high rate of deep responses. #ASH25

54 13 1 0
3 months ago
Post image Post image Post image

Wow!! 🔥🔥 CDK4/6 inhibition prevents selection of #ClonalHematopoiesis with DNA-damage repair mutations after chemotherapy! Awesome presentation from Irenaeus Chan from @kellybolton.bsky.social lab! #ASH25

20 3 0 0
3 months ago

#ASH25 let’s goooooo

1 0 0 0
5 months ago
Post image

📚 This T-cell NHL diagnostic slide has been circulating and provides a nice framework
#medsky #hemesky #hemeonc #lymphoma #pathsky #hemepath #Tcells #cellmarkers #biology #hematology #medicine #pathology #oncology #oncsky #diagnostics #meded

2 0 0 0
5 months ago
Preview
Final CAPTIVATE Analysis Data Support Frontline Fixed-Duration Ibrutinib Plus Venetoclax in CLL/SLL | OncLive Paolo Ghia, MD, PhD, details the final analysis of the phase 2 CAPTIVATE study evaluating frontline ibrutinib/venetoclax in patients with CLL.

Final CAPTIVATE Analysis Data Support Frontline Fixed-Duration Ibrutinib Plus Venetoclax in CLL/SLL
#CLL #Hematology
www.onclive.com/view/final-c...

0 1 0 0
6 months ago

All signed up for the 2025 ASH Annual Meeting. Looking forward to it! #hemesky #ASH25

2 0 0 0
6 months ago

🩸 ISTH DIC score (overt ≥ 5)
Plt <50=2; 50–100=1
PT >6s=2; 3–6s=1
Fibrinogen <1.0g/L=1
D-dimer: >3× ULN=3; 1–3× ULN=2; none=0
#hemesky #medsky #coag #benignheme

0 0 0 0
8 months ago
Video thumbnail

Join us on October 25 for a packed day of thrombosis education for healthcare professionals. Register today at thrombosiscanada.ca/2025Conference

0 2 0 0
6 months ago
Preview
Mosunetuzumab/Polatuzumab Vedotin Is an Effective Off-the-Shelf Combo in R/R MCL Treatment with mosunetuzumab plus polatuzumab vedotin yielded high response rates and had a manageable safety profile in BTK inhibitor–exposed MCL.

Mosunetuzumab/Polatuzumab Vedotin Is an Effective Off-the-Shelf Combo in R/R MCL @mdanderson.bsky.social @societyofhemonc.bsky.social #SOHO2025 #lymsm #hematology
www.onclive.com/view/mosunet...

2 1 0 0
6 months ago

🩺 Differentiation Syndrome
- complication that can occur during treatment of APL w/ ATRA+ATO

Clinical:
⬆️ WBCs
⬆️ Fever
⬆️ edema/body weight/pulmonary infiltrates

Mgmt:
- high-dose steroids
- cytoreduction
- antipyretics / cxs / abx for FN
- diuresis

#hemesky #hemeonc #medsky #APL #APML #leukemia

0 0 0 0
6 months ago

Not hard to tell that I’m currently on thrombosis! Having a good experience with the team here at McMaster. #thrombosis #hemesky #hematology

1 0 0 0
7 months ago
Preview
Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation Compelling evidence supports the need to update the 2001 definition and diagnosis of disseminated intravascular coagulation (DIC) to reflect our curre…

"Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation."
Publié en juillet dans J Thromb Haemost.
#MedSky #DIC
www.sciencedirect.com/science/arti...

0 1 0 0
6 months ago

🩸📖 NEJM 2003: CLOT trial - 676 patients w/ cancer-associated thrombosis (CAT) - Dalteparin vs warfarin.

Dalteparin dose: 200 IU/kg sc daily ×1/12 → 150 IU/kg daily ×5/12 (total 6 months).

Outcome: ↓ recurrent VTE; no ↑ major bleed in the group who received dalteparin.

#hemesky #thrombosis #medsky

1 0 0 0
7 months ago

🩸Cancer-associated Thrombosis Trials: LMWH more effective than VKAs

CANTHANOX 2002:
Enoxaparin vs VKA

CLOT 2003:
Dalteparin vs VKA

ONCENOX 2006:
Enoxaparin vs VKA

LITE 2006:
Tinzaparin vs VKA

CATCH 2015:
Tinzaparin vs VKA

#thrombosis #clinicalTrials #hemesky #medsky #IMsky #oncology #hemeonc

0 0 0 0
7 months ago

CARAVAGGIO 2020 (1,170 pts):

Apixaban vs dalteparin for cancer VTE. Recurrent VTE 5.6 % vs 7.9 % (non-inf). Major bleed 3.8 % vs 4.0 %; no extra GI bleed. Bottom line: apixaban noninferior to dalteparin without increase in major bleeding in cancer-associated VTE. #medsky #hemesky #thrombosis

0 0 0 0
7 months ago
Post image

Lesson from this past week:

Isolated elevation of anticardiolipin IgM does not meet laboratory criteria for antiphospholipid syndrome! According to EULAR 2023 guidelines below. #medsky #IMsky #rheumsky #hemesky #antiphospholipid #thrombosis

1 0 0 0
7 months ago
Post image

Ven is effective (91% ORR) and well tolerated in octogenarians, but 43% hd treatment holds and 32% prolonged ramp-up. buff.ly/lNgBN1r #hemesky

1 1 0 0
7 months ago

Monoclonal Gammopathy: Paraneoplastic Neuropathy 🧠🩸

AL Amyloidosis: painful + length-dependent + sensory > motor
POEMS: symmetric disabling demyelinating polyneuropathy
DADS-M: distal loss of proprioception + demyelinating + coarse tremor + mild motor weakness

#hemesky #myeloma #medsky #neurosky

1 0 0 0
9 months ago
Figure 1.  Pathogenesis of CML and Mechanism of Action of Available BCR::ABL1 TKIs

Chronic myeloid leukemia is a myeloproliferative neoplasm.

This Review summarizes the epidemiology, diagnosis, and management of chronic myeloid leukemia.

https://ja.ma/4mlR6ez

6 3 0 0
9 months ago

Thanks for the added detail! 🔬

0 0 0 0
9 months ago
Post image

Unveiling the enigma: circulating flowerlike large B-lymphoma cells in the context of angioimmunoblastic T-cell lymphoma
buff.ly/bbBzTQG #hemesky #lymphoidneoplasia

1 1 0 0
10 months ago
Post image

🔬🩸Hemoglobin development (some fundamentals!)

Embryo
Hb Gower I = ζ2ε2
Hb Gower II = α2ε2
Hb Portland = ζ2γ2

Fetus
HbF = α2γ2

Adult
HbA = α2β2 ~97%
HbA2 = α2δ2 ~2–3%
HbF <1%
#hemesky #medsky #IMsky #benignheme #hemoglobin #pediatrics

2 1 0 0
1 year ago
Preview
JAK Inhibitor–Based Combos and Mutation-Specific Regimens Comprise the Future of Myelofibrosis Management Claire Harrison, MD, FRCP, FRCPath, discusses research that may evolve the clinical use of JAK inhibitors and mutation-specific therapies in myelofibrosis.

JAK Inhibitor–Based Combos and Mutation-Specific Regimens Comprise the Future of Myelofibrosis Management
#MPNsm #hematology #oncology
www.onclive.com/view/jak-inh...

5 1 0 0
1 year ago
Blood film picture of a patient with CML showing a variety of immature and mature white blood cells

Workin. CML in a 27 Year old. #haematology #hematology

0 1 0 0
1 year ago
Post image

💊 Abatacept

Humanized protein construct from recombinant DNA (CTLA4 + IgG1 Fc) grown in hamster ovary cells.

Selectively binds to CD80/86 on APCs, inhibiting CD80/86-CD28 costimulatory signal essential for full T-cell activation.

#medsky #IMsky #rheumsky #biologics
(Herrero-Beaumont et al., 2012)

0 0 1 0
1 year ago
Preview
Isatuximab Plus VRd Wins EU Approval for Newly Diagnosed, Transplant-Ineligible Multiple Myeloma The EMA’s CHMP has approved isatuximab in combination with VRd for transplant-ineligible patients with newly diagnosed multiple myeloma.

Isatuximab Plus VRd Wins EU Approval for Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
#mmsm #Hematology
www.onclive.com/view/isatuxi...

4 2 0 0
1 year ago
Video thumbnail

This recently published study highlights the prognostic significance of high-risk cytogenetic abnormalities in multiple myeloma. Genetic alterations like t(4;14), del(17p), and +1q are linked to poorer prognosis and shorter survival  #MM #hematology 👉https://bit.ly/3PzY1BT

7 1 0 0
1 year ago

This looks awesome! 🔬🤩

1 0 1 0
1 year ago

Congratulations to you! Wishing you good health going forward ♥️

1 0 0 0